1. How to use GuruFocus - Tutorials
  2. What Is in the GuruFocus Premium Membership?
  3. A DIY Guide on How to Invest Using Guru Strategies
Shuda Xia
Shuda Xia
Articles (102) 

Weekly Top Insider Buys Highlight for the Week of July 14

The largest Insider Buys were for Analog Devices, Dollar Tree, AZZ Dova Pharmaceuticals

July 16, 2017 | About:

The largest Insider Buys this week were for Analog Devices Inc. (NASDAQ:ADI), Dollar Tree Inc. (NASDAQ:DLTR), AZZ Inc. (NYSE:AZZ) and Dova Pharmaceuticals Inc. (NASDAQ:DOVA).

Analog Devices Inc (NASDAQ:ADI): Director Bruce R. Evans bought 14,000 Shares

Director Bruce R. Evans bought 14,000 shares of ADI stock on July 7 at the average price of $78.28. The price of the stock has increased by 4.18% since.

Analog Devices Inc. is an international semiconductor company that specializes in data conversion and signal processing technology. It is headquartered in Norwood, Massachusetts. In 2012, the company led the worldwide data converter market with a 48.5% share. The company has a market cap of $29.93 billion, and as of July 14 it traded at $81.55.

On May 31, NextEra Analog Devices Inc reported first quarter 2017 financial results. The company had a GAAP revenue of $1.1 billion, with a contribution of $147.5 million from Linear Technology. The company also reported a GAAP diluted earnings per share of 27 cents, and a quarterly cash dividend of 45 cents per outstanding share of common stock.

Dollar Tree Inc (NASDAQ:DLTR): Director Conrad M. Hall Bought 5,000 Shares

Director Conrad M. Hall bought 5,000 shares of DLTR stock on July 10 at the average price of $66.16. The price of the stock has increased by 4.46% since.

Dollar Tree Inc. is an American Fortune 500 chain of discount variety stores that sells items at $1 or less. The company operates 13,600 stores in 48 U.S. states and Canada. Products include health and beauty, food, décor, houseware, toys and household cleaning supplies. The company has a market cap of $16.36 billion, and as of July 14 it traded at $69.11.

On June 9, Dollar Tree Inc. announced that Michael A. Witynski has been promoted to President and Chief Operating Officer of the Dollar Tree segment of the company. Mr. Witynski will be responsible for merchandising and marketing and store operations for more than 6,200 Dollar Tree bannered stores in the U.S. Mr. Witynski has previously served as Senior Vice President of Stores since joining Dollar Tree in 2010.

AZZ Inc.: Senior Vice President and CFO Paul Wesley Fehlman bought 1,500 shares

Senior Vice President and CFO Paul Wesley Fehlman bought 1,500 shares of AZZ stock on July 11 at the average price of $49.31. The price of the stock has increased by 3.93% since.

AZZ Inc. is an American international specialty equipment and component manufacturer for power generation, transmission, and distribution. The company also provides hot dip galvanizing services to the steel fabrication market in the United States and Canada. The company has a market cap of $1.33 billion, and as of July 14 it traded at $51.25.

On July 6, AZZ Inc. reported first quarter 2018 financial results. The company reported a net revenue of $208.6 million compared to $242.7 million for the same quarter last year, a decrease of 14.1%. Furthermore, the company reported a net income of $13.2 million, or 51 cents per diluted share, compared to net income of $21.1 million, or 81 cents per diluted share for the first quarter of fiscal 2017. This amounts to a $37.1% decrease for net income.

Dova Pharmaceuticals Inc. (NASDAQ:DOVA): Director Steven M. Goldman bought 72,000 shares

Director Steven M. Goldman bought 72,000 shares of Dova stock on July 5 at the average price of $17.94. The price of the stock has increased by 33.95% since.

Dova Pharmaceuticals Inc. is an American clinical stage pharmaceutical company focused on acquiring, developing, and commercializing drug candidates for rare diseases. The company’s lead compound is avatrombopag, a second generation thrombopoetin receptor agonist that is being evaluated for use in the treatment of patients with thrombocytopenia. The company has a market cap of $600.5 million, and as of July 14 it traded at $24.03.

On June 28 Dova Pharmaceuticals Inc. announced the pricing of its initial public offering of 4,415,000 shares of its common stock at a public offering price of $17.00 per share, for total gross proceeds of approximately $75.1 million. Furthermore, the company has granted the underwriters a 30 day option to purchase up to an additional 662,250 shares of common stock at the public offering price.

For the complete list of stocks that were bought by their company executives, go to: Insider Trades.

Disclosure: I do not own stock in any of the companies mentioned in the article.

  • CEO Buys, CFO Buys: Stocks that are bought by their CEO/CFOs.
  • Insider Cluster Buys: Stocks that multiple company officers and directors have bought.
  • Double Buys:: Companies that both Gurus and Insiders are buying
  • Triple Buys: Companies that both Gurus and Insiders are buying, and Company is buying back.

» Take a Free Trial of Premium Membership


Rating: 0.0/5 (0 votes)

Comments

Please leave your comment:


Performances of the stocks mentioned by Shuda Xia


User Generated Screeners


fluidityinglassShort%20Squeeze%20high%20F,%20
opadovaniP Median2 No DIV
cegdevelopmentthe best managers
cegdevelopmentprof managers
cegdevelopmentguru goals
cegdevelopmentguru holding
opadovaniFCF Growth
DBrizanROTA22nov2017 943p
pbarker4652 week
pbarker46E&P CDN
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

{{numOfNotice}}
FEEDBACK